Nom du chef de service BRUNO MARCHOU Mail : marchou.b@chu-toulouse.fr
Thématique 1 : PALUDISME
Mots clés : malaria – antimalarial (drug) – innate immunity
Responsable scientifique : Antoine BERRY Françoise BENOIT-VICAL
Mail : berry.b@chu-toulouse.fr ; Francoise.Vical@toulouse.fr
Intitulé de l’équipe : Service de parasitologie-mycologie (Pr MAGNAVAL) ; CNRS LCC
Encadrement de master ou thèse oui
Thématique 2 : INFECTION VIH_SIDA
Mots clés : HIV – tropism - reservoir
Responsable scientifique : Jacques IZOPET Pierre DELOBEL
Mail : izopet.j@chu-toulouse.fr ; delobel.p@chu-toulouse.fr
Intitulé de l’équipe : Inserm U 563
Encadrement de master ou thèse oui
Thématique 3 : TUBERCULOSE
Mots clés : M tuberculosis - granuloma - treatment
Responsable scientifique : Frédéric ALTARE Mail : frederic.altare@ipbs.fr
Intitulé de l’équipe : IPBS-CNRS
Encadrement de master ou thèse oui
1: Izopet J, Marchou B, Charreau I, Sauné K, Tangre P, Molina JM, Aboulker JP; Window (ANRS 106) Study Team. HIV-1-resistant strains during 8-week on 8-week off intermittent therapy and their effect on CD4+ T-cell counts and antiviral response. Antivir Ther. 2008;13(4):537-45.
2: Cuzin L, Delpierre C, Gerard S, Massip P, Marchou B. Immunologic and clinical responses to highly active antiretroviral therapy in patients with HIV infection aged >50 years. Clin Infect Dis. 2007 Sep 1;45(5):654-7.
3: Delpierre C, Bonnet E, Marion-Latard F, Aquilina C, Obadia M, Marchou B,Massip P, Perret B, Bernard J. Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls. J Clin Densitom. 2007 Oct-Dec;10(4):376-80.
4: Martin-Blondel G, Barry M, Porte L, Busato F, Massip P, Benoit-Vical F, Berry A, Marchou B. Impact of HIV infection on malaria in adults Med Mal Infect. 2007 Oct;37(10):629-36. Review. French.
5: Delpierre C, Dray-Spira R, Cuzin L, Marchou B, Massip P, Lang T, Lert F; the VESPA Study Group. Correlates of late HIV diagnosis: implications for testing policy. Int J STD AIDS. 2007 May;18(5):312-7.
6: Delobel P, Nugeyre MT, Cazabat M, Pasquier C, Marchou B, Massip P, Barre-Sinoussi F, Israël N, Izopet J. Population-based sequencing of the V3 region of env for predicting the coreceptor usage of human immunodeficiency virus type 1 quasispecies. J Clin Microbiol. 2007 May;45(5):1572-80.
7: Marchou B, Tangre P, Charreau I, Izopet J, Girard PM, May T, Ragnaud JM,Aboulker JP, Molina JM; ANRS 106 Study team. Intermittent antiretroviral therapy in patients with controlled HIV infection. AIDS. 2007 Feb 19;21(4):457-66
8: Delobel P, Nugeyre MT, Cazabat M, Sandres-Sauné K, Pasquier C, Cuzin L,Marchou B, Massip P, Cheynier R, Barré-Sinoussi F, Izopet J, Israël N. Naive T-cell depletion related to infection by X4 human immunodeficiency virus type 1 in poor immunological responders to highly active antiretroviral therapy. J Virol. 2006 Oct;80(20):10229-36.
9: Berry A, Senescau A, Lelièvre J, Benoit-Vical F, Fabre R, Marchou B, MagnavalJF. Prevalence of Plasmodium falciparum cytochrome b gene mutations in isolates imported from Africa, and implications for atovaquone resistance. Trans R Soc Trop Med Hyg. 2006 Oct;100(10):986-8.
10: Delobel P, Sandres-Sauné K, Cazabat M, L'Faqihi FE, Aquilina C, Obadia M, Pasquier C, Marchou B, Massip P, Izopet J. Persistence of distinct HIV-1 populations in blood monocytes and naive and memory CD4 T cells during prolonged suppressive HAART. AIDS. 2005 Nov 4;19(16):1739-50.
